eQMS Software: Electronic Quality Management for Regulated Industries

Cloud-native. Regulated-industry built. Part 11 ready.

eQMS Software: A Cloud-Hosted Electronic Quality Management System Built for Pharma, Medical Device, and Regulated Manufacturing

Buyers searching for eQMS software have already made one decision: paper-based or hybrid quality management systems are not adequate for their needs. The question is not whether to operate an electronic quality management system. The question is which electronic QMS platform best fits the regulatory requirements, organizational complexity, and validation obligations of a regulated-industry quality system.

This page covers what an eQMS must deliver for regulated industries, the specific requirements for pharmaceutical and medical device eQMS deployments, how cloud deployment satisfies 21 CFR Part 11, and what to look for when evaluating eQMS platforms.

eQMS vs. QMS: The Distinction That Drives the Search

The ‘e’ in eQMS is not a marketing prefix. It reflects a material difference in how quality system records are created, stored, reviewed, and retrieved. A paper-based QMS generates paper records: batch records completed by hand, SOPs printed and signed, deviation reports written and filed in binders, and CAPA records managed in spreadsheets. These systems are auditable but inefficient, error-prone at every manual step, and incapable of connecting related records at the system level. A hybrid system combines electronic tools — SharePoint for documents, Excel for CAPA tracking, a standalone LMS for training records — without the integration that makes electronic quality management meaningful.

An electronic quality management system manages every quality record electronically, enforces quality system workflows at the system level, maintains 21 CFR Part 11-compliant audit trails across all record types, and connects quality events to their downstream obligations — training requirements, CAPA actions, change control reviews — through system record relationships rather than manual handoffs. The buyer who has searched for eQMS software is looking for the third option: a system where the quality management processes themselves are electronic and integrated, not just the documents that describe them.

The regulatory consequence of this distinction is visible during FDA inspections. An investigator reviewing a paper or hybrid system examines the paper trail. An investigator reviewing an eQMS examines the system itself: the audit trail of who accessed and modified every record, the workflow history showing how each record moved through its lifecycle stages, and the electronic signature records confirming who approved each document and when. The eQMS produces more complete inspection evidence than a paper system can — if the eQMS was built correctly.

Pharmaceutical eQMS Requirements: ICH Q10 and the Electronic Quality System

ICH Q10 describes the pharmaceutical quality system as having four principal elements: knowledge management, quality risk management, corrective and preventive action, and change management. Section 1.6 of ICH Q10 specifically addresses the use of quality management system software, noting that electronic systems can enhance the effectiveness of the pharmaceutical quality system when they are validated and controlled. The ICH Q10 framework is the architectural blueprint for a pharmaceutical eQMS.

ICH Q10 Section 1.6.1: Knowledge Management in the eQMS

ICH Q10 Section 1.6.1 addresses knowledge management as a key enabler of the pharmaceutical quality system, requiring that the organization support the capture, management, and use of knowledge accumulated through product and process development, technology transfer, commercial manufacturing, and product discontinuation. In an eQMS, knowledge management means that batch production data, deviation history, process validation records, CAPA history, and change control records are accessible as a connected knowledge base rather than dispersed across paper files, binders, and offline spreadsheets. eLeaP’s eQMS connects these record types through system relationships: a deviation links to the batch in which it occurred, the CAPA that addressed its root cause, and the change control that modified the process. The knowledge management enabler of ICH Q10 Section 1.6.1 is satisfied by the record architecture, not by a separate knowledge management tool.

ICH Q10 Section 3.2.2: CAPA in the Electronic Quality System

ICH Q10 Section 3.2.2 requires that a CAPA system address the root cause of nonconformities and verify the effectiveness of corrective actions. The effectiveness verification requirement in ICH Q10 is the element that distinguishes a mature pharmaceutical quality system from one that manages CAPA documentation without managing CAPA outcomes. In eLeaP’s pharmaceutical eQMS, the CAPA workflow requires effectiveness criteria to be defined before corrective action implementation, schedules verification at a defined monitoring interval, and prevents CAPA closure without a completed effectiveness verification sign-off. The electronic enforcement of this requirement — the system prevents closure, it does not simply remind the user — is the advantage of an eQMS over a paper or hybrid CAPA system.

ICH Q10 Section 3.2.3: Change Management in the eQMS

ICH Q10 Section 3.2.3 requires that changes to processes, equipment, analytical methods, and quality system elements be controlled through a formal change management process that includes impact assessment, approval, and post-implementation review. The electronic advantage in change management is the connection between the change record and the downstream obligations: the documents requiring revision, the revalidation activities required, and the training assignments that gate implementation. In eLeaP, the change control record is connected to all three through system relationships. The change does not close until each obligation is satisfied.

Batch Records and GMP Documentation in the Pharmaceutical eQMS

21 CFR Part 211.188 requires batch production and control records for each batch of drug product. An electronic batch record system within the eQMS captures each production step with operator identity, server-generated timestamps, and entered values. Out-of-range entries are flagged as deviations and automatically create deviation records in the quality management system without manual routing. The batch release review presents the complete batch record, all in-process test results, and all linked deviation records in a single view for the quality control reviewer. The batch record is retrievable by batch number or lot number in seconds, satisfying the inspection retrieval expectation that paper archives cannot reliably meet.

Medical Device eQMS: DHF Management, DHR Maintenance, and Post-Market Quality Surveillance

Medical device eQMS requirements are governed by QMSR (the Quality Management System Regulation, effective February 2, 2026, harmonized with ISO 13485:2016), and for EU market access, EU MDR 2017/745 and applicable harmonized standards. The medical device eQMS has distinctive requirements that pharmaceutical and general manufacturing eQMS platforms do not address with the same depth: Design History File management, Device History Record maintenance, Medical Device Report evaluation, and post-market surveillance quality management.

Design History File in the Medical Device eQMS

QMSR and its predecessor 21 CFR Part 820.30(j) require that a Design History File be established and maintained for each type of device, containing or referencing the records demonstrating that the device was developed in accordance with the approved design plan. ISO 13485 Section 7.3 governs design and development controls for medical device manufacturers operating under the harmonized standard. An eQMS that manages the DHF as a document folder satisfies the letter of these requirements inadequately — the records exist, but their relationships to each other are not maintained by the system. An eQMS that manages the DHF as a navigable record network satisfies both the letter and the inspection expectation: an auditor can trace from any user need to the design input that addresses it, to the design output that implements it, to the verification test that confirms it, to the validation study that validates the device meets the user need.

eLeaP’s medical device eQMS maintains the DHF as a record network. Design inputs link to their source and to the outputs they drove. Outputs link to verification tests. Verification tests link to the inputs they verify. Design changes link to the DHF records they modify and to the CAPA records that originated them. The traceability matrix is a live view of these system relationships, not a manually maintained document.

Device History Record and Post-Market Quality Surveillance

ISO 13485 Section 4.2.5 requires a medical device file containing or referencing records demonstrating conformity to requirements and demonstrating that each manufactured unit was produced in accordance with the Device Master Record. Post-market quality surveillance under QMSR and EU MDR requires that feedback from the field — complaints, vigilance reports, post-market clinical follow-up data — feeds back into the quality system as inputs for CAPA, design change decisions, and risk management updates. An eQMS that connects the DHR for each produced unit to the complaint records for that device family, and connects complaint trends to design change initiation, creates the post-market quality surveillance architecture that QMSR and EU MDR require.

eLeaP’s medical device eQMS links DHR records to the DMR version in effect at the time of production, to equipment qualification records for equipment used, and to training records for operators who performed each production step. Complaint records link to the complaint trend analysis and, where a trend indicates a design-related quality issue, to the design change record initiated in response. The post-market quality surveillance loop — from field complaint to trend analysis to design change to updated DHF — is a connected record chain in the eQMS rather than a manual aggregation exercise.

MDR Evaluation in the Medical Device eQMS

21 CFR Part 803 requires medical device manufacturers to report to the FDA when a device may have caused or contributed to a death or serious injury, or when a device malfunctioned and would be likely to cause or contribute to a death or serious injury if it recurred. The MDR evaluation is a required workflow stage in every complaint that may involve a device malfunction with patient impact. An eQMS that manages complaint handling without a structured MDR evaluation workflow — one that walks through the Part 803 reportability criteria, documents the determination with rationale, and tracks the submission date against the applicable 30-day or 5-day reporting window — is not a medical device eQMS in the regulatory sense.

eLeaP’s medical device eQMS includes the MDR evaluation workflow as a required stage in the complaint record for device malfunction and adverse event complaints. The evaluation fields walk through the Part 803 criteria. The determination and rationale are captured in the record’s permanent history. MDR submission tracking records the submission date against the reporting window and generates escalation notifications for approaching deadlines. MDR amendment records link to the original MDR submission within the complaint record.

Cloud eQMS Deployment: Hosting, Security, and 21 CFR Part 11 Compliance

Cloud deployment of an eQMS raises three questions that regulated-industry buyers consistently ask: where are my records hosted, is the system secure enough for GxP data, and how do cloud-hosted electronic records satisfy 21 CFR Part 11? Each question has a specific answer for eLeaP’s cloud deployment architecture.

Data Hosting and Infrastructure

eLeaP’s eQMS is hosted on enterprise cloud infrastructure with defined specifications for availability, data isolation, geographic redundancy, backup frequency, and disaster recovery capability. The hosting environment specifications are documented in the Installation Qualification report provided to customers as part of the validation support package. Data is hosted in the geographic region selected at implementation, with options appropriate for US-regulated, EU-regulated, and multi-region deployments. Backup procedures run at defined intervals with tested recovery procedures. Infrastructure access is restricted to authorized personnel and is logged in the infrastructure access audit trail, separate from the application-layer audit trail.

Security Architecture for GxP Data

GxP data in eLeaP’s cloud eQMS is protected through encryption at rest and in transit, role-based access controls that restrict data access to authorized users and roles, multi-factor authentication options for user account access, and session timeout controls that terminate inactive sessions after a configurable interval. The security architecture documentation, including penetration testing reports and security control descriptions, is available to customers under NDA as part of the due diligence process. Customers in regulated environments with specific security requirements — SOC 2 Type II compliance, specific data residency requirements, or integration with enterprise identity management systems — are assessed as part of the implementation scoping process.

21 CFR Part 11 Compliance in a Cloud-Hosted eQMS

21 CFR Part 11 does not distinguish between records maintained on-premises and records maintained in cloud-hosted systems. The regulation applies to electronic records subject to FDA regulations, regardless of where those records are physically stored. Cloud-hosted electronic records satisfy Part 11 if the system satisfies Part 11’s technical and procedural requirements: computer-generated time-stamped audit trails that are tamper-evident and user-inaccessible for modification, electronic signatures that are unique to one individual and require two-factor authentication at the time of signing, and system validation demonstrating accuracy and reliability.

In a cloud eQMS, the validation responsibility is shared between the cloud provider and the regulated user in a specific way that differs from on-premises installations. The cloud provider — eLeaP in this case — is responsible for the Installation Qualification of the hosting infrastructure and the Operational Qualification of the application. The regulated user is responsible for the Performance Qualification against their specific configured workflows and for ongoing validation maintenance through the system’s change control process. eLeaP provides the IQ report, OQ test library, Part 11 traceability matrix, and PQ protocol templates as part of the validation support package. The customer executes the PQ and generates the validation summary report.

The audit trail in eLeaP’s cloud eQMS is maintained in a separately secured audit log database hosted in the same infrastructure as the application data. The audit trail is tamper-evident: it is inaccessible for modification by any user, including system administrators, and the database-layer separation between operational data and audit log data is documented in the system architecture documentation. Cloud hosting does not weaken the audit trail architecture — it strengthens it, because the audit trail infrastructure is maintained by eLeaP with enterprise-grade availability and backup procedures rather than being dependent on the customer’s on-premises IT infrastructure.

What Separates a Regulated-Industry eQMS from a General-Purpose Platform

The eQMS market includes platforms built for general quality management, platforms built for specific regulated industries, and platforms marketed to regulated buyers without the underlying architecture to support regulated-industry requirements. The distinctions are not visible in marketing materials — they are visible in the system’s behavior when a document is revised, a CAPA is investigated, a batch is released, or an audit begins.

A regulated-industry eQMS is distinguished by four architectural characteristics that general-purpose platforms consistently lack.

Native LMS Integration at the Data Layer

Most eQMS platforms offer a training module. A training module tracks completions. A native integrated LMS, built in the same platform and sharing the same record structure as the QMS, does something the training module cannot: it connects training obligations directly to document versions, role assignments, and quality event records. When a document is revised, the eQMS automatically identifies every role assigned to that document and creates training assignments for every affected employee — without any manual action by a training administrator. When a CAPA root cause identifies a training gap, the training assignment is created from within the CAPA record and its completion is tracked as a condition of corrective action closure. This connection — between quality record changes and training obligations — exists only when the QMS and LMS share the same platform at the data layer.

Workflow Enforcement Rather Than Workflow Suggestion

A paper QMS relies on trained personnel to follow defined procedures. A hybrid system sends reminders and tracks completions. A regulated-industry eQMS enforces workflow logic at the system level: a CAPA cannot advance to effectiveness verification until all corrective action items are documented as complete; a document cannot be published without completed approval signatures from all required approvers; a batch cannot be released without all in-process deviations resolved. The system does not remind users to complete these requirements — it prevents advancement until they are met. This enforcement is the compliance advantage of an eQMS over paper and hybrid systems, and it is the capability that FDA investigators and auditors look for when they examine an electronic quality system.

Regulated-Industry Validation Support

An eQMS for regulated industries is not just software — it is software that a regulated organization must validate before using for GxP records. A vendor that provides only a ‘validated platform’ statement without an executed IQ report, OQ test library with Part 11 traceability matrix, and PQ protocol templates is not providing the validation support that a regulated buyer needs. The validation support package must include: the executed IQ confirming the hosting infrastructure was installed per specification; the OQ test library with executed test results for all core functions including all Part 11-relevant functions; a Part 11 compliance traceability matrix mapping each Part 11 requirement to the system capability and OQ test that demonstrates compliance; CSA risk classification documentation; and PQ protocol templates structured around use case scenarios. eLeaP provides all of these as part of the standard validation support package, available for review before contract signature.

Record Linkage Across Quality Event Types

In a regulated quality system, quality events do not occur in isolation. A deviation initiates a CAPA. A CAPA drives a document revision. A document revision triggers training. A change control requires revalidation and updated training before closure. A complaint may require an MDR submission. These connections should exist as system record relationships — navigable links between records in the eQMS — not as manually maintained cross-references in separate systems. An eQMS that holds each record type in a separate module without system-level linkage between them replicates the fragmentation of a hybrid system within a single application.

Evaluating eQMS Software: Five Questions for the Regulated-Industry Buyer

Use these five questions in every eQMS evaluation. They test the capabilities that differentiate a regulated-industry eQMS from a general-quality management platform delivered via a browser.

eLeaP’s eQMS demo covers all five questions live, in a cloud-hosted environment configured for the buyer’s regulatory framework and industry. The demo includes the training integration demonstration, the DHF record network view for medical device buyers, and the batch record execution workflow for pharmaceutical buyers. Request a scoped eQMS demo at eleapsoftware.com.

Frequently Asked Questions: eQMS Software

What is eQMS software?

eQMS software — electronic quality management system software — is a cloud-hosted or on-premises platform that manages all quality system records and workflows electronically, with enforced workflow logic, tamper-evident audit trails, and electronic signatures that satisfy 21 CFR Part 11. The ‘e’ is material: an eQMS does not simply store quality documents electronically. It enforces the quality system processes — CAPA workflow stages, document approval sequences, change control requirements, training completion gates — at the system level, and connects quality events to their downstream obligations through system record relationships rather than manual handoffs.

How does an eQMS differ from a QMS?

A QMS is the overall quality management system — the policies, procedures, processes, and records that an organization uses to manage quality. A QMS can be paper-based, hybrid, or electronic. An eQMS is the electronic implementation of a QMS: all records are created, stored, reviewed, and retrieved electronically, all workflows are enforced by the system, and all audit trails are computer-generated and tamper-evident. The practical distinction is one of enforcement: a paper QMS relies on trained personnel to follow defined procedures, while an eQMS enforces those procedures at the system level and prevents advancement to the next stage until the current stage’s requirements are met.

Does a cloud-hosted eQMS satisfy 21 CFR Part 11?

Yes. 21 CFR Part 11 does not distinguish between records maintained on-premises and records maintained in cloud-hosted systems. The regulation applies to electronic records subject to FDA requirements regardless of where those records are physically stored. A cloud-hosted eQMS satisfies Part 11 if it meets Part 11’s technical requirements: computer-generated, time-stamped audit trails that are tamper-evident and inaccessible for modification; electronic signatures that are unique to one individual and require two-factor authentication at the time of signing; and system validation demonstrating accuracy and reliability. The validated state of a cloud-hosted eQMS is demonstrated through the same IQ/OQ/PQ qualification framework that applies to on-premises systems, with the IQ covering the cloud hosting infrastructure and the OQ covering the application functions.

What are the eQMS requirements for pharmaceutical manufacturers?

Pharmaceutical eQMS requirements are framed by ICH Q10, which describes the pharmaceutical quality system around four elements: knowledge management (ICH Q10 Section 1.6.1), quality risk management, corrective and preventive action (Section 3.2.2), and change management (Section 3.2.3). A pharmaceutical eQMS must support all four: connected record architecture for knowledge management, structured CAPA workflows with effectiveness verification enforcement, and change control records linked to downstream document revision and training obligations. Additional requirements from 21 CFR Part 211 apply to specific record types: batch production and control records under Part 211.188, personnel training under Part 211.25, and written procedures under Part 211.100. The electronic batch record system within the eQMS must capture each production step with operator identity, server-generated timestamps, and entered values, with automatic deviation flagging and deviation record creation.

What are the eQMS requirements for medical device manufacturers?

Medical device eQMS requirements are governed by QMSR (the Quality Management System Regulation, effective February 2, 2026, harmonized with ISO 13485:2016) and, for EU market access, EU MDR 2017/745. A medical device eQMS must manage the Design History File as a navigable record network (not a document folder), maintain Device History Records linked to the DMR version in effect at the time of production, include a structured MDR evaluation workflow for complaints involving potential device malfunctions, and support post-market quality surveillance by connecting complaint trends to design change initiation and CAPA. ISO 13485 Section 7.3 governs design and development controls. ISO 13485 Section 4.2.5 requires the medical device file demonstrating conformity to requirements across the device lifecycle. The eQMS must support traceability from any design input to the verification and validation evidence that confirms it — a requirement that a document folder cannot satisfy.

What validation documentation should an eQMS vendor provide?

A regulated-industry eQMS vendor should provide: an executed IQ report confirming the hosting infrastructure was installed and configured per documented specifications; an OQ test library with executed test results for all core application functions, with specific coverage of all 21 CFR Part 11-relevant functions (audit trail, electronic signatures, access control); a Part 11 compliance traceability matrix mapping each Part 11 requirement to the system capability and OQ test that demonstrates it; CSA risk classification documentation covering each QMS function by FDA Computer Software Assurance category; PQ protocol templates structured around use case scenarios for each major system function; and advance change notification with CSA risk classification for each change and identification of the OQ tests affected. Generic ‘FDA compliant’ or ‘validated’ statements without this documentation package do not satisfy the regulated user’s validation obligation.

Why does a regulated-industry eQMS need a native integrated LMS?

Training compliance in a regulated quality system is inseparable from document control: when a procedure is revised, every employee performing tasks governed by that procedure has a training obligation against the new version. A standalone LMS tracks training completions but has no connection to the document control system — it cannot know that the SOP version a person was trained on has been superseded. A native integrated LMS, built in the same platform as the QMS and sharing the same record structure, connects training obligations directly to document versions. When a document reaches effective status, the system automatically creates training assignments for all affected roles with the document version number embedded in the assignment. When a CAPA root cause identifies a training gap, the training assignment is created from within the CAPA record and tracked as a corrective action item. This connection exists at the data layer — it is not an integration between two separate systems that can break.

Request a Scoped eQMS Demo

eLeaP’s eQMS demo covers all five evaluation questions live, in a cloud-hosted environment configured for the buyer’s regulatory framework and industry: the training integration demonstration, the DHF record network view for medical device buyers, and the batch record execution workflow for pharmaceutical buyers. Request a scoped eQMS demo.

Related resources: